AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 188 filers reported holding AKERO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $112 | +107.4% | 10,600 | -5.4% | 0.01% | +37.5% |
| Q2 2023 | $54 | -19.4% | 11,200 | -41.4% | 0.01% | +14.3% |
| Q1 2023 | $67 | -78.4% | 19,100 | -61.7% | 0.01% | -73.1% |
| Q4 2022 | $310 | -99.7% | 49,900 | +10.6% | 0.03% | +333.3% |
| Q3 2022 | $98,000 | +263.0% | 45,100 | +1704.0% | 0.01% | +500.0% |
| Q1 2021 | $27,000 | +12.5% | 2,500 | +56.2% | 0.00% | -50.0% |
| Q3 2020 | $24,000 | +9.1% | 1,600 | +60.0% | 0.00% | +100.0% |
| Q2 2020 | $22,000 | +266.7% | 1,000 | +233.3% | 0.00% | – |
| Q1 2020 | $6,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 5,830,203 | $179,512,000 | 24.20% |
| venBio Partners LLC | 2,444,311 | $75,260,000 | 11.44% |
| Versant Venture Management, LLC | 777,727 | $23,946,000 | 4.38% |
| Redmile Group, LLC | 2,336,357 | $71,936,000 | 1.32% |
| Vivo Capital, LLC | 571,833 | $17,607,000 | 1.02% |
| Cormorant Asset Management, LP | 859,550 | $26,466,000 | 1.02% |
| Boxer Capital, LLC | 831,495 | $25,602,000 | 0.88% |
| Integral Health Asset Management, LLC | 85,000 | $2,617,000 | 0.80% |
| EAM Global Investors LLC | 49,718 | $1,531,000 | 0.56% |
| Crawford Lake Capital Management, LLC | 43,826 | $1,349,000 | 0.56% |